Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Public Citizen Calls For Removal of Medical Malpractice Settlement Reporting “Loophole” September 27, 2016 Irvin Jackson Add Your Comments The prominent consumer watchdog group Public Citizen is criticizing federal regulators for failing to close a loophole that allows doctors to get away without reporting medical malpractice payments. Public Citizen issued a statement on September 22, indicating that the U.S. Department of Health and Human Services (HHS) rejected a petition to fix what is known as the “corporate shield” loophole for doctors and healthcare workers. According to the group, it allows health care providers to avoid reporting medical malpractice settlements to the National Practitioner Data Bank (NPDB). In May 2014, Public Citizen filed a petition calling for HSS and the Health Resources and Services Administration (HRSA) to issue a notice of proposed rulemaking to address the loophole. HRSA proposed such a rulemaking in December 24, 1998, but declined to pursue it. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HRSA filed a response (PDF) on September 21, rejecting a May 2014 petition by Public Citizen, which filed a lawsuit (PDF) over the decision in July. “HRSA’s denial of Public Citizen’s petition to close the corporate shield loophole represents an abject failure of the agency to act in the best interests of patient safety and public health,” Dr. Michael Carome, director of Public Citizen’s Health Research Group, said in the statement. “The agency’s terse denial letter offers little substantive explanation justifying its action.” Carome said that the loophole is not consistent with federal law, and undercuts the NPDB’s mission to ensure patient safety by providing information on malpractice payments and the disciplinary history of doctors and health care workers. However, the HRSA letter says that it rejected the petition, and previous proposed rule to close the loophole due to comments it received during the public comment period. The HRSA letter says that the vast majority of comments it received were in opposition to the rule, saying that it was overly broad, that current regulations exist to address the problem, and that HHS may not have the legal authority to address the problem. “In HRSA’s view, the regulatory solution proposed in the NPRM and again suggested by Public Citizen in its May 2014 letter is not a viable answer for many of the reasons raised by commenters to the 1998 NPRM,” the HRSA letter states. “Though HRSA remains open as how to address the ‘corporate shield,’ HRSA is currently unaware of any regulatory mechanism that does not raise similar concerns.” Carome stated that the letter and HRSA’s actions indicate that the agency is more protecting doctors who provide substandard care than it is protecting patients. Tags: Medical Malpractice More Lawsuit Stories Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit March 25, 2025 Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025 Cases of Persistent Delirium at Nursing Homes Dropped in Recent Years: Study March 25, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: today) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025) Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: yesterday) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025) Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 4 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)
Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: today) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)
Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: yesterday) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 4 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)